AVEO制药 AVEO 深 沪
等待开盘 08-25 09:30:00 美东时间
15.00
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 15.00
- 总市值 52.14万
- 52周最高 15.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.06
- 委 比 0.00%
- 总股本 3.48万
- 历史最高 189.30
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.23
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026
Kura Oncology announced updated Phase 1a results from the FIT-001 trial showing encouraging clinical activity of darlifarnib plus cabozantinib in cabozantinib-naïve patients with advanced clear cell renal cell carcinoma (ccRCC). The combination demonstrated a response rate of 33%-50%, median PFS of 13 months, and durable clinical benefit. Safety was manageable, consistent with individual agent profiles. The findings support the potential of darli...
07-27 10:32
Verastem Oncology任命Michael P. Bailey为董事会成员
专注于RAS/MAPK通路驱动型癌症的生物制药公司Verastem Oncology今日宣布，任命Michael P． Bailey为公司董事会成员。与此同...
05-26 23:17
LG化学头颈部癌治疗新药启动Ⅲ期临床试验
LG化学官微消息，旗下抗癌新药研发公司AVEO Pharmaceuticals将在美国正式启动头颈癌新药Ficlatuzumab的Ⅲ期临床试验（试验名称：FI...
2024-01-17 11:21
StockNews.com上调了AVEO制药（纳斯达克股票代码：AVEO）的股票评级
AVEO Pharmaceuticals (NASDAQ:AVEO – Get Rating) was upgraded by stock analysts ...
2023-01-10 16:11
Aveo制药公司(纳斯达克代码：Aveo)股价创下一年新高，至14.98美元
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) shares reached a new 52-w...
2022-12-30 17:32
AVEO Pharmicals, Inc.（纳斯达克股票代码：AVEO）给出分析师平均建议 “持有”
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) has earned an average rec...
2022-12-28 16:51
AVEO Pharmicals（纳斯达克股票代码：AVEO）创下52周新高，为14.95美元
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) shares reached a new 52-w...
2022-12-23 06:42
AVEO Pharmicals, Inc.（纳斯达克股票代码：AVEO）的空头利率下降了21.2％
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) saw a large decline in sh...
2022-12-18 22:41
